BCYC - Bicycle Therapeutics Plc - ADR
IEX Last Trade
21.515
-0.145 -0.674%
Share volume: 63,602
Last Updated: Fri 30 Aug 2024 09:59:21 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$21.66
-0.15
-0.67%
Summary score
25%
Profitability
25%
Dept financing
10%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.77%
Return on assets
-7.51%
Return on sales
-671.16%
Return on invested capital
243.57%
Total debt ratio
36.4%
Debt ratio change over timeo
-0.74%
Current Ratio
8.91%
Quick Ratio
9.06%
Cash Position Ratio
8.12%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.01%
Return on assets
-8.09%
Return on sales
-626.78%
Return on invested capital
147.02%
Total debt ratio
39.76%
Debt ratio change over timeo
-0.67%
Current Ratio
8.2%
Quick Ratio
8.2%
Cash Position Ratio
7.43%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-7.46%
Return on assets
-5.8%
Return on sales
-162.4%
Return on invested capital
144.92%
Total debt ratio
34.93%
Debt ratio change over time
-0.74%
Current Ratio
10.42%
Quick Ratio
10.42%
Cash Position Ratio
9.23%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-108.62%
Return on assets
-105.31%
Return on sales
-524.07%
Return on invested capital
24.91%
Total debt ratio
-74.1%
Debt ratio change over time
-0.74%
Current Ratio
4.75%
Quick Ratio
4.73%
Cash Position Ratio
4.19%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BCYC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.77% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.51% | 2.76% | 3.15% | 5.62% |
| Return on sales | -671.16% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 243.57% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 57% |
| Total debt ratio | 36.4% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.74% | 308.97% | -6.99% | 1.18% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 8.2% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 8.2% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 7.43% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 6% | 13% | 29% |
| Short-term ratios | BCYC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.01% | 13.77% | 13.25% | 3.8% |
| Return on assets | -8.09% | 2.43% | 1.89% | 3.09% |
| Return on sales | -626.78% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 147.02% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 39.76% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.67% | 46.38% | -72.08% | 1.51% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 8.2% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 8.2% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 7.43% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 6% | 16% | 40% |